Goodwill and Intangible Assets

3 Months Ended

Apr. 01, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

The following table provides a rollforward of the Company’s goodwill:



			Adjustments to Goodwill
	December 31, 2016		Acquisitions / (Divestitures)			Transfers		Foreign Exchange		April 1, 2017

	(in thousands)
DSA	$	563,476	$	(427	)	$	—	$	3,074	$	566,123
RMS	56,397		—			—		182		56,579
Manufacturing	167,644		(35,857		)	—		1,533		133,320
Total	$	787,517	$	(36,284	)	$	—	$	4,789	$	756,022

The reduction of goodwill of $35.9 million relates to the divestiture of the CDMO business within the Manufacturing reportable segment.

Intangible Assets, Net

The following table displays intangible assets, net by major class:



	April 1, 2017							December 31, 2016
	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net

	(in thousands)
Backlog	$	7,782	$	(7,351	)	$	431	$	8,370	$	(6,390	)	$	1,980
Technology	72,241		(17,171		)	55,070		71,425		(14,314		)	57,111
Trademarks and trade names	8,271		(4,204		)	4,067		8,177		(4,124		)	4,053
Other	16,794		(6,026		)	10,768		16,775		(5,628		)	11,147
Other intangible assets	105,088		(34,752		)	70,336		104,747		(30,456		)	74,291
Client relationships	506,406		(206,929		)	299,477		519,123		(198,966		)	320,157
Intangible assets	$	611,494	$	(241,681	)	$	369,813	$	623,870	$	(229,422	)	$	394,448

During the three months ended April 1, 2017, the Company divested the CDMO business, which resulted in a net decrease of $16.8 million and $0.3 million to client relationships and backlog, respectively. During the three months ended March 26, 2016, the Company determined that the carrying values of certain DSA intangible assets were not recoverable and recorded an impairment charge of $1.9 million, which was included in costs of services provided (excluding amortization of intangible assets) within the Company’s unaudited condensed consolidated statements of income.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details